Finally some good news for women about HIV meds. This piece covers research into Cabotegravir from ViiV. After much medical research excluding women, this was actually aimed at their needs.
Cabotegravir was developed as a maintenance med for those with well controlled HIV. However, instead of a daily pill, it's an injection given every 2 months. This led to it's use as a PrEP drug.
I normally oppose PrEP, But, this med has shown to be effective. It also means people have to see medical professional.
The primary seller here is this research was done in Africa. This medication means these women can take the drug without anyone else knowing. They don't have to fear stigma as much. It helps lessen exposure if their partner isn't cooperative or they're assaulted.
In these instances, this med has proven to be 80% more effective than Truvada. That's staggering. Between that & its discreet nature, I can't oppose it. Especially under these circumstances. If this article doesn't work for you, this info is easily found on the net.
Cya...
No comments:
Post a Comment